Such markers of inflammation include elevated dysfunctional HDL, increased IL-6 [46], increased leptin [47], and decreased adiponectin [47] which have demonstrated associations with NASH in the literature and our prior studies. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.